Sample Size Re-estimation - Biopharmnet

Mis-specification of nuisance parameters (e.g. variance for a normally distributed outcome or underlying response rate for binary outcomes), can have a large impact on power and sample size. No matter what source of information is the basis for pre-trial assumptions, it is only the data from the trial itself that will verify or refute these ... ................
................